ArticlePublic health challenges2026
Medication Adherence and Health-Related Quality of Life Among Hypertensive Patients in Nepal: A Cross-Sectional Study.
Article in Public health challenges, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Good adherence to antihypertensive medication is critical for optimal blood pressure control and reducing disease-related complications. This study aimed to assess patients' medication adherence and health-related quality of life (HRQoL) and explore the relationship between medication adherence and HRQoL among hypertensive patients. Methods: A cross-sectional study was carried out at the Scheer Memorial Adventist Hospital (SMAH) in Bagmati Province, Nepal, from March 2023 to June 2023. The General Medication Adherence Scale (GMAS) and the European Quality of Life-5 Dimensions-5 Levels (EQ-5D-5L) questionnaires were used to assess medication adherence and HRQoL, respectively. Logistic regression analysis was employed to explore the relationship between participants' characteristics, medication adherence levels, and HRQoL impairment across the five dimensions of EQ-5D-5L. Statistical significance was set at Results: A total of 300 patients were surveyed, of whom only 52.33% were adherent to their antihypertensive medication. Similarly, the mean (±SD) GMAS score of the participants was 25.21 (±6.5), and the mean (SD) EQ index and EQ-VAS scores were 0.84 ± 0.22 and 72.22 ± 11.67, respectively. The percentages of issues in various dimensions were 47.3% for mobility, 19.66% for self-care, 26.66% for usual activities, 70.33% for pain/discomfort, and 58% for anxiety/depression. Multiple logistic regression analysis revealed that higher education attainment, longer disease duration, and enrollment to health insurance schemes were significantly associated with improve patients' medication adherence ( Conclusions: Medication adherence was suboptimal in substantial proportion of hypertensive patients. Adherence to medication was linked to an improved HRQoL in patients with hypertension regardless of sociodemographic and clinical variables.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.